2023
DOI: 10.1007/s11764-023-01395-0
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating the effect of upper-body morbidity on quality of life following primary breast cancer treatment: a systematic review and meta-analysis

Abstract: Purpose Improvements in breast cancer management continue to increase survival and life expectancy after treatment. Yet the adverse effects of treatment may persist long term, threatening physical, psychological, and social wellbeing, leading to impaired quality of life (QOL). Upper-body morbidity (UBM) such as pain, lymphoedema, restricted shoulder range of motion (ROM), and impaired function are widely reported after breast cancer treatment, but evidence demonstrating its impact on QOL is incon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 119 publications
0
1
0
Order By: Relevance
“…Shoulder pain and dysfunction can greatly impact quality of life for cancer survivors, affecting their physical, psychological, and social well-being [2,114,115]. It is critical to consider multiple etiologies of shoulder impairment, many of which are secondary to cancer treatments, such as postbreast surgery pain syndrome, radiation fibrosis syndrome and inflammatory arthralgia from hormonal and immunotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Shoulder pain and dysfunction can greatly impact quality of life for cancer survivors, affecting their physical, psychological, and social well-being [2,114,115]. It is critical to consider multiple etiologies of shoulder impairment, many of which are secondary to cancer treatments, such as postbreast surgery pain syndrome, radiation fibrosis syndrome and inflammatory arthralgia from hormonal and immunotherapy.…”
Section: Discussionmentioning
confidence: 99%